South Korea · Biotechnology startup
South Korea · Autotelic Bio
Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.
Funding reportedLast round: Series B
What company datasets say Autotelic Bio raised
Funding, as reported
Reported in all22Bin the source's currency
Rounds3
Last roundSeries B
Last round dateMar 2022
Investors listed12
Biotechnology in South Korea
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Autotelic Bio in front of investors. Or tell us what we have wrong.